CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $488,645 | -54.1% | 17,756 | -43.4% | 0.00% | -33.3% |
Q2 2023 | $1,064,214 | +47.0% | 31,365 | +55.9% | 0.00% | 0.0% |
Q1 2023 | $724,062 | +131.8% | 20,124 | +187.2% | 0.00% | +200.0% |
Q4 2022 | $312,347 | -19.5% | 7,008 | -49.2% | 0.00% | 0.0% |
Q3 2022 | $388,000 | -49.2% | 13,789 | -51.3% | 0.00% | 0.0% |
Q2 2022 | $764,000 | +13.4% | 28,320 | +43.2% | 0.00% | 0.0% |
Q1 2022 | $674,000 | -61.4% | 19,776 | -56.3% | 0.00% | 0.0% |
Q4 2021 | $1,747,000 | +18.8% | 45,208 | +65.9% | 0.00% | -50.0% |
Q3 2021 | $1,471,000 | +67.3% | 27,251 | +3.7% | 0.00% | +100.0% |
Q2 2021 | $879,000 | -48.4% | 26,283 | -68.2% | 0.00% | -66.7% |
Q1 2021 | $1,702,000 | +302.4% | 82,637 | +242.1% | 0.00% | +200.0% |
Q4 2020 | $423,000 | +2388.2% | 24,159 | +140.0% | 0.00% | – |
Q1 2020 | $17,000 | -29.2% | 10,065 | -7.4% | 0.00% | – |
Q4 2019 | $24,000 | -36.8% | 10,870 | -39.1% | 0.00% | – |
Q3 2019 | $38,000 | +100.0% | 17,837 | +157.1% | 0.00% | – |
Q2 2019 | $19,000 | -64.8% | 6,937 | -36.6% | 0.00% | -100.0% |
Q1 2019 | $54,000 | – | 10,948 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |